CYBB and Alzheimer disease: Zhang H et al. found that ginsenosides Rg1 treatment significantly reduced the expression of NOX2 in H2O2-treated neurons, thus reducing ROS levels in the cortex and hippocampus, suggesting that Rg1 may alleviate cognitive dysfunction in AD by inhibiting NOX2-mediated neuronal oxidative stress (Zhang et al., 2021).